BIB
BIB, or ProShares Ultra Biotech, is an exchange-traded fund (ETF) designed to provide twice the daily return of the S&P Biotechnology Select Industry Index. It is a leveraged ETF, aiming to deliver 2x the daily performance of the underlying index.
Asset Summary
Loading summary…
Asset Performance Metrics and Risk Characteristics:
Metrics below use daily returns for Jan 1, 2026 – Aug 23, 2026 (YTD).
Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.
1 Month Trailing Return
23.34%
Represents the percentage change in asset value over the past month.
3 Month Trailing Return
48.04%
Indicates the percentage change in asset value over the last three months.
Period Max Drawdown
16.93%
The highest percentage drop from the peak value to the lowest point during the observed period.
Standard Deviation
47.20%
Shows how much the asset’s daily returns deviate from the average, annualized for the entire period.
Sharpe Ratio
1.66
Measures the average return earned in excess of the risk-free rate per unit of volatility, annualized.
Calmar Ratio
4.63
The ratio of the annualized return to the maximum drawdown, reflecting the return per unit of risk.
Asset Technical Analysis
Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.
Analysis
Moving Averages
Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:
| Type/Period | |
|---|---|
| SMA | |
| EMA | |
| WMA | |
| WEMA |
- SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
- EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
- WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
- WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.
Optimize Your BIB Trading Now
Maximize your trading efficiency with OHLCX Platform. Our advanced trading system provides detailed insights and actionable strategies for BIB. Don’t wait—Transform your trading strategy now and see how our platform can help you achieve your trading goals!
Unlock Full Potential NowFrequently Asked Questions
-
BIB has an expense ratio of approximately 0.95%. This fee represents the cost of managing the fund, including administrative and operational expenses, and is expressed as a percentage of the fund’s average net assets.
-
BIB aims to deliver twice the daily return of the S&P Biotechnology Select Industry Index. However, due to its leveraged nature, performance can diverge significantly over longer periods due to compounding effects and daily rebalancing.
-
Risks include high volatility and the potential for substantial losses due to the leveraged nature of the ETF. BIB’s performance is highly sensitive to daily changes in the biotech sector, and its use of leverage can amplify both gains and losses.
-
Key performance metrics for BIB include its net asset value (NAV), expense ratio, daily return performance, and leverage ratio. BIB's performance is designed to be twice that of the S&P Biotechnology Select Industry Index on a daily basis.
-
Factors influencing BIB’s performance include movements in the biotechnology sector, changes in the S&P Biotechnology Select Industry Index, market volatility, and the effects of leverage. The ETF’s performance is also impacted by its daily rebalancing and compounding effects.
-
Similar ETFs to BIB include: LABU (Direxion Daily S&P Biotech Bull 3X Shares), which seeks to provide three times the daily performance of the S&P Biotechnology Select Industry Index; IBB (iShares Nasdaq Biotechnology ETF), which tracks the Nasdaq Biotechnology Index and provides exposure to biotechnology and pharmaceutical companies; and XBI (SPDR S&P Biotech ETF), which tracks the S&P Biotechnology Select Industry Index and provides broad exposure to the biotech sector.
-
BIB typically distributes dividends on a quarterly basis. These dividends are generated from income produced by the underlying securities in the ETF, though leveraged ETFs may have lower yield compared to non-leveraged funds.
-
BIB is managed by ProShares and seeks to achieve its investment objective by using financial instruments, including derivatives such as futures contracts, options, and swap agreements. It aims to provide leveraged exposure to the biotechnology sector.
-
Investors can purchase shares of BIB through a brokerage account. It is traded on major stock exchanges under the ticker symbol "BIB" and can be bought and sold like other stocks and ETFs.
-
Yes, BIB can be held in retirement accounts such as IRAs or 401(k)s. However, due to its leveraged nature and higher risk profile, it’s important to consider how it fits within your overall investment strategy and risk tolerance.
Top Market Assets
Discover our curated selection of top-performing exchange-traded funds (ETFs) that represent a diverse range of investment opportunities.
SPY is an exchange-traded fund (ETF) that aims to replicate the performance of the S&P 500 Index. The S&P 500 Index includes 500 of the largest publicly traded companies in the United States, representing a broad cross-section of the U.S. economy.
QQQ is an exchange-traded fund (ETF) that tracks the performance of the Nasdaq-100 Index. This index includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market, primarily focusing on technology and innovation sectors.
DIA is an exchange-traded fund (ETF) that aims to track the performance of the Dow Jones Industrial Average (DJIA). The DJIA is a stock market index consisting of 30 large, publicly traded companies in the United States, representing a broad range of industries.
IWM is an exchange-traded fund (ETF) that seeks to track the performance of the Russell 2000 Index. The Russell 2000 Index measures the performance of the 2,000 smallest stocks in the Russell 3000 Index, representing a broad segment of small-cap U.S. companies.
Optimize Your BIB Trading Now
Unlock the full potential of BIB with OHLCX execution platform’s cutting-edge automated trading system. Our platform provides precise price action analysis, advanced technical indicators, and powerful quantitative algorithms. Enhance your market performance today and transform your trading experience today!
Disclaimers
The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.
With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.
Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.
Securities products are: Not FDIC insured · Not bank guaranteed · May lose value
Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.